Human NRXN1(Neurexin1) ELISA Kit – ATO8784
ATO8784
Size:Price:
48 T$320.00
96 T$458.00
Download

Overview

Product name: Human NRXN1(Neurexin1) ELISA Kit
Reactivity: Human
Alternative Names: Neurexin-1; Neurexin I-alpha; Neurexin-1-alpha; NRXN1; KIAA0578
Assay Type: Sandwich
Sensitivity: 26.5 pg/mL
Standard: 5000 pg/mL
Detection Range: 78.13-5000 pg/mL
Sample Type: serum, plasma and other biological fluids
Assay Length: 3.5h
Research Area: Autistic Disorder
Uniprot ID: Q9ULB1
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human NRXN1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human NRXN1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human NRXN1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm 10nm. The concentration of Human NRXN1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (pg/mL) OD Corrected OD
5000.00 2.207 2.111
2500.00 1.642 1.546
1250.00 1.067 0.971
625.00 0.933 0.837
312.50 0.576 0.480
156.25 0.239 0.143
78.13 0.225 0.129
0.00 0.096 0.000

Precision

Intra-assay Precision (Precision within an assay):CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays):CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant NRXN1 and the recovery rates were calculated by comparing the measured value to the expected amount of NRXN1 in samples.
Matrix Recovery range Average
serum(n=5) 80-97% 88%
EDTA plasma(n=5) 78-92% 85%
Heparin plasma(n=5) 90-105% 97%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of NRXN1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 86-96% 85-97% 89-101% 85-97%
EDTA plasma(n=5) 87-98% 92-104% 82-96% 95-102%
Heparin plasma(n=5) 80-92% 86-102% 87-103% 85-101%